Goudman Lisa, Jansen Julie, Billot Maxime, Vets Nieke, De Smedt Ann, Roulaud Manuel, Rigoard Philippe, Moens Maarten
Department of Neurosurgery, Universitair Ziekenhuis Brussel, Jette, Belgium.
STIMULUS, Vrije Universiteit Brussel, Jette, Belgium.
JMIR Serious Games. 2022 May 10;10(2):e34402. doi: 10.2196/34402.
Virtual reality (VR) is a computer technology that immerses a user in a completely different reality. The application of VR in acute pain settings is well established. However, in chronic pain, the applications and outcome parameters influenced by VR are less clear.
This review aimed to systematically identify all outcome parameters that are reported in relation to VR in patients with chronic pain.
A total of 4 electronic databases (PubMed, Scopus, Web of Science, and Embase) were searched for relevant studies. Multilevel random-effect meta-analyses were performed, whereby the standardized mean difference was chosen as the effect size to denote the difference between measurements before and after a VR intervention.
The initial database search identified 1430 studies, of which 41 (2.87%) were eventually included in the systematic review. Evidence has been found for the effects of VR on pain, functioning, mobility, functional capacity, psychological outcomes, quality of life, neuropsychological outcomes, and physical sensations. The overall effect size (a total of 194 effect sizes from 25 studies) based on a three level meta-analysis was estimated at 1.22 (95% CI 0.55-1.89; z=3.56; P<.001), in favor of improvements after a VR intervention. When categorizing effect sizes, the overall effect sizes were reported as follows: 1.60 (95% CI 0.83-2.36; z=4.09; P<.001) for the effect of VR on pain (n=31), 1.40 (95% CI 0.13-2.67; z=2.17; P=.03) for functioning (n=60), 0.49 (95% CI -0.71 to 1.68; z=0.80; P=.42) for mobility (n=24), and 0.34 (95% CI -1.52 to 2.20; z=0.36; P=.72) for functional capacity (n=21).
This systematic review revealed a broad range of outcome variables influenced by an intervention of VR technology, with statistically significant pain relief and improvements in functioning. These findings indicate that VR not only has applications in acute pain management but also in chronic pain settings, whereby VR might be able to become a promising first-line intervention as complementary therapy for patients with chronic pain.
PROSPERO International Prospective Register of Systematic Reviews CRD42021227016; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=227016.
虚拟现实(VR)是一种将用户沉浸在完全不同现实中的计算机技术。VR在急性疼痛环境中的应用已得到充分证实。然而,在慢性疼痛中,受VR影响的应用和结果参数尚不清楚。
本综述旨在系统地确定与慢性疼痛患者VR相关的所有结果参数。
共检索了4个电子数据库(PubMed、Scopus、Web of Science和Embase)以查找相关研究。进行了多层次随机效应荟萃分析,选择标准化平均差作为效应量来表示VR干预前后测量值之间的差异。
初步数据库检索确定了1430项研究,其中41项(2.87%)最终纳入系统评价。已发现VR对疼痛、功能、活动能力、功能容量、心理结果、生活质量、神经心理结果和身体感觉有影响。基于三级荟萃分析的总体效应量(来自25项研究的总共194个效应量)估计为1.22(95%CI 0.55 - 1.89;z = 3.56;P <.001),表明VR干预后有改善。对效应量进行分类时,总体效应量报告如下:VR对疼痛的效应量为1.60(95%CI 0.83 - 2.36;z = 4.09;P <.001)(n = 31),对功能的效应量为1.40(95%CI 0.13 - 2.67;z = 2.17;P =.03)(n = 60),对活动能力的效应量为0.49(95%CI -0.71至1.68;z = 0.80;P =.42)(n = 24),对功能容量的效应量为0.34(95%CI -1.52至2.20;z = 0.36;P =.72)(n = 21)。
本系统评价揭示了受VR技术干预影响的广泛结果变量,在疼痛缓解和功能改善方面具有统计学意义。这些发现表明,VR不仅可应用于急性疼痛管理,也可应用于慢性疼痛环境,VR可能成为慢性疼痛患者有前景的一线辅助治疗干预措施。
PROSPERO国际系统评价前瞻性注册库CRD42021227016;https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=227016 。